The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer (BioSpace News, 11 January 2010)

18 Jan 2010


A partnership formed between the Institut Curie and Ipsogen could lead to a better understanding of the diagnosis and personalised treatment of breast cancers, as the Institut shares its library of breast tumours to help evaluate Ipsogen's HER2 and HR genetic tests.

Full article


Share this story